Enflame Technology IPO Online Subscription Oversubscribed 6,109 Times with Hit Rate of Only 0.025%
nashnova research
Enflame Technology's STAR Market IPO drew 6,109× oversubscription in the retail tranche — over 7 million individual accounts bid, and the hit rate landed at just 0.025%, the market's most emphatic bet yet on China's domestic AI-chip substitution play.
6,109× oversubscribed — how extreme is that?
Over 7 million retail investor accounts submitted bids; the online hit rate was just 0.025%. This means → roughly 1 in every 4,000 applicants will get shares.
Overwhelming demand forced the company to shift 3.4 million shares from the offline (institutional) tranche to online, raising the retail allocation from 6.89 million shares (20%) to 10.33 million shares (30%).
In plain terms = retail demand was so intense that the company had to "borrow" stock from the institutional pool to feed it.
The "Four Little GPU Dragons" — who are they?
Enflame is the last of the so-called "Four Little GPU Dragons" — China's four leading AI-chip startups — to complete a public listing.
The other three — Moore Threads (688795), Biren Technology (688802), and Iluvatar CoreX (6082.HK) — all listed within the past year.
This reflects a clear capital-market signal: the domestic GPU track has entered its public-pricing phase, with all four runners now trading in the open.
What does the money go toward?
The IPO is priced at ¥142.18 per share, with roughly 43 million shares on offer, targeting about ¥6.1 billion (~$908 million) in proceeds.
Funds are earmarked for R&D and production of fifth- and sixth-generation AI chips and supporting hardware and software.
This means → Enflame is not raising capital to maintain the status quo — it is betting on the next two product generations. Whether it can keep pace with AI compute iteration hinges on this money.
Tencent is both top shareholder and top customer — is that healthy?
Tencent holds roughly 20% of Enflame's equity and is simultaneously its largest shareholder and largest customer.
In 2025, Tencent-related sales accounted for 84% of Enflame's total revenue, up sharply from about 38% the prior year.
In plain terms = Enflame is, for now, essentially "Tencent's AI-chip supplier." The upside: order visibility is extremely high. The risk: any shift in Tencent's demand or supplier preference would hit revenue hard.
Revenue is doubling — so why is the company still losing money?
Enflame expects H1 2026 revenue to more than triple year-on-year, reaching ¥10.6–11.5 billion; its 2023–2025 revenue CAGR exceeded 80%.
Yet the 2025 net loss was still ¥1.2 billion (narrowed from ¥1.5 billion the year before), with a projected H1 2026 loss of about ¥600 million.
This means → chip development is a classic "burn first, earn later" cycle — revenue is scaling, but R&D and production-line spending have not yet been diluted by volume. The break-even inflection point has not arrived.
Behind the retail frenzy — what is the real bet?
After the U.S. tightened export controls on advanced chips and chipmaking equipment to China, Beijing accelerated domestic substitution. The market share held by Nvidia and other U.S. suppliers is seen as a window of opportunity for homegrown players.
Investor enthusiasm is, at its core, a wager on how far China's domestic AI chips can go in filling that gap.
But the core variables have not disappeared — extreme customer concentration in Tencent and ongoing losses remain the fundamental test of whether the current valuation can be sustained.
市场有风险，内容仅供研究参考，不构成投资建议。